Premium
[P4–330]: DISTINGUISHING LEGAL CONSEQUENCES IN AT‐RISK TESTING FOR ALZHEIMER's DISEASE: GENETICS VERSUS NON‐GENETIC BIOMARKERS
Author(s) -
Arias Jalayne J.
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.2200
Subject(s) - genetic discrimination , legislation , federal law , genetic testing , biomarker , disease , medicine , political science , psychology , law , genetics , biology , pathology